BlackRock Fund Advisors’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$258K Buy
245
+8
+3% +$3.63K ﹤0.01% 3359
2016
Q3
$95K Sell
237
-1
-0.4% -$408 ﹤0.01% 3633
2016
Q2
$98K Buy
238
+75
+46% +$36.7K ﹤0.01% 3676
2016
Q1
$70K Sell
163
-12
-7% -$4.64K ﹤0.01% 3744
2015
Q4
$101K Buy
175
+8
+5% +$5.61K ﹤0.01% 3728
2015
Q3
$149K Sell
167
-5
-3% -$4.56K ﹤0.01% 3585
2015
Q2
$177K Buy
172
+21
+14% +$24.6K ﹤0.01% 3571
2015
Q1
$215K Buy
151
+16
+12% +$20.3K ﹤0.01% 3463
2014
Q4
$188K Buy
135
+49
+57% +$70.8K ﹤0.01% 3502
2014
Q3
$105K Sell
86
-6
-7% -$8.62K ﹤0.01% 3632
2014
Q2
$167K Sell
92
-733
-89% -$979K ﹤0.01% 3547
2014
Q1
$1.34M Buy
825
+26
+3% +$54.4K ﹤0.01% 3173
2013
Q4
$1.03M Sell
799
-37
-4% -$59.1K ﹤0.01% 3193
2013
Q3
$1.68M Buy
+836
New +$1.55M ﹤0.01% 3146

Other funds holding HSTO

BlackRock Fund Advisors's HSTO Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Histogen Inc. Common Stock (HSTO) stake by 3.4% in Q4 2016, buying an estimated $3.63K and bringing the position to 245 shares worth $258K. The position accounts for ﹤0.01% of the portfolio, ranked #3359.

BlackRock Fund Advisors first reported a position in HSTO in Q3 2013 and has held it in 14 quarters since. The position peaked at $1.68M in Q3 2013. 41 funds tracked by Wall St. Rank hold HSTO as of Q4 2016.

  • BlackRock Fund Advisors held 245 shares of Histogen Inc. Common Stock worth $258K as of Q4 2016.
  • BlackRock Fund Advisors bought 8 Histogen Inc. Common Stock shares in Q4 2016, an estimated $3.63K.
  • Histogen Inc. Common Stock made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3359 holding.
  • BlackRock Fund Advisors first reported a position in Histogen Inc. Common Stock in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Fund Advisors's Histogen Inc. Common Stock position peaked at $1.68M in Q3 2013.
  • 41 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.